| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH4 MYO6 KIF26B RSF1 PEX1 MSH3 RFC1 DNAH14 IQCA1L ATAD1 CLU DDX18 HLTF POLQ DDX21 TOP2B | 3.25e-07 | 614 | 112 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 8.11e-05 | 127 | 112 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.90e-04 | 441 | 112 | 10 | GO:0016887 | |
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 4.61e-04 | 6 | 112 | 2 | GO:0008510 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 6.94e-04 | 262 | 112 | 7 | GO:0140097 | |
| GeneOntologyMolecularFunction | DNA topoisomerase activity | 8.54e-04 | 8 | 112 | 2 | GO:0003916 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH4 ENPP1 RSF1 PEX1 RFC1 IQCA1L ATAD1 CLU DDX18 HLTF POLQ DDX21 RAB5A | 8.57e-04 | 840 | 112 | 13 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH4 ENPP1 RSF1 PEX1 RFC1 IQCA1L ATAD1 CLU DDX18 HLTF POLQ DDX21 RAB5A | 8.57e-04 | 840 | 112 | 13 | GO:0016818 |
| Domain | P-loop_NTPase | MYH4 MYO6 KIF26B PEX1 MSH3 RFC1 DNAH14 EHD3 EHD2 LRRIQ1 ATAD1 DDX18 HLTF DSEL POLQ DDX21 RAB5A HYDIN | 2.50e-06 | 848 | 111 | 18 | IPR027417 |
| Domain | - | PEX1 MSH3 RFC1 DNAH14 EHD3 EHD2 ATAD1 DDX18 HLTF DSEL POLQ DDX21 RAB5A HYDIN | 1.35e-04 | 746 | 111 | 14 | 3.40.50.300 |
| Domain | Toprim | 2.08e-04 | 4 | 111 | 2 | PF01751 | |
| Domain | Toprim_domain | 2.08e-04 | 4 | 111 | 2 | IPR006171 | |
| Domain | TOPRIM | 2.08e-04 | 4 | 111 | 2 | PS50880 | |
| Domain | EHD_N | 3.46e-04 | 5 | 111 | 2 | IPR031692 | |
| Domain | Na/HCO3_transpt | 3.46e-04 | 5 | 111 | 2 | IPR003024 | |
| Domain | EHD_N | 3.46e-04 | 5 | 111 | 2 | PF16880 | |
| Domain | GAR | 5.17e-04 | 6 | 111 | 2 | PS51460 | |
| Domain | GAS2 | 5.17e-04 | 6 | 111 | 2 | PF02187 | |
| Domain | - | 5.17e-04 | 6 | 111 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 5.17e-04 | 6 | 111 | 2 | IPR003108 | |
| Domain | GAS2 | 5.17e-04 | 6 | 111 | 2 | SM00243 | |
| Domain | IQ | 8.45e-04 | 71 | 111 | 4 | PF00612 | |
| Domain | - | 1.23e-03 | 9 | 111 | 2 | 3.40.1100.10 | |
| Domain | Band3_cytoplasmic_dom | 1.23e-03 | 9 | 111 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 1.23e-03 | 9 | 111 | 2 | PF07565 | |
| Domain | IQ | 1.38e-03 | 81 | 111 | 4 | SM00015 | |
| Domain | PTrfase/Anion_transptr | 1.53e-03 | 10 | 111 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 1.53e-03 | 10 | 111 | 2 | IPR003020 | |
| Domain | HCO3_cotransp | 1.53e-03 | 10 | 111 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 1.53e-03 | 10 | 111 | 2 | IPR011531 | |
| Domain | EF-hand_4 | 1.53e-03 | 10 | 111 | 2 | PF12763 | |
| Domain | EH | 1.86e-03 | 11 | 111 | 2 | PS50031 | |
| Domain | EH | 1.86e-03 | 11 | 111 | 2 | SM00027 | |
| Domain | EH_dom | 1.86e-03 | 11 | 111 | 2 | IPR000261 | |
| Domain | IQ_motif_EF-hand-BS | 2.04e-03 | 90 | 111 | 4 | IPR000048 | |
| Domain | IQ | 2.30e-03 | 93 | 111 | 4 | PS50096 | |
| Domain | G_DYNAMIN_dom | 3.04e-03 | 14 | 111 | 2 | IPR030381 | |
| Domain | G_DYNAMIN_2 | 3.04e-03 | 14 | 111 | 2 | PS51718 | |
| Domain | Dynamin_GTPase | 3.49e-03 | 15 | 111 | 2 | IPR001401 | |
| Domain | Dynamin_SF | 3.49e-03 | 15 | 111 | 2 | IPR022812 | |
| Domain | Dynamin_N | 3.49e-03 | 15 | 111 | 2 | PF00350 | |
| Domain | AAA | 3.65e-03 | 52 | 111 | 3 | PF00004 | |
| Domain | Helicase_C | 3.81e-03 | 107 | 111 | 4 | PF00271 | |
| Domain | HELICc | 3.81e-03 | 107 | 111 | 4 | SM00490 | |
| Domain | Helicase_C | 3.94e-03 | 108 | 111 | 4 | IPR001650 | |
| Domain | ATPase_AAA_core | 4.07e-03 | 54 | 111 | 3 | IPR003959 | |
| Domain | HELICASE_CTER | 4.07e-03 | 109 | 111 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 4.07e-03 | 109 | 111 | 4 | PS51192 | |
| Domain | DEXDc | 4.07e-03 | 109 | 111 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 4.21e-03 | 110 | 111 | 4 | IPR014001 | |
| Domain | BRCT | 5.60e-03 | 19 | 111 | 2 | PF00533 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 6.14e-05 | 116 | 83 | 6 | MM15715 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 6.30e-05 | 170 | 83 | 7 | M941 | |
| Pubmed | NOLC1 MYH4 AHCYL1 UBTD2 GGNBP2 CUX2 ZNF789 IFT81 PARP8 RSF1 NOC3L SGO1 ESF1 NMI DST BBX ZNF608 RBM5 TNFAIP8 CADPS2 POLQ DDX21 RPL3L TOP3B TOP2B | 4.23e-12 | 1442 | 112 | 25 | 35575683 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NOLC1 CHERP GTSE1 RSF1 NOC3L BUD13 RFC1 NSRP1 ESF1 RIF1 SCML2 BBX PRPF3 DDX18 STAU2 PDCD11 DDX21 LCOR TOP2B | 2.26e-10 | 954 | 112 | 19 | 36373674 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NOLC1 NOC3L BUD13 DBT RFC1 ESF1 RIF1 PRPF3 DDX18 STAU2 PDCD11 DDX21 METTL17 TOP3B TOP2B | 2.34e-08 | 759 | 112 | 15 | 35915203 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NOLC1 CASP8AP2 CHERP MCPH1 MSH3 RFC1 ATF2 RIF1 SCML2 DST BBX PRPF3 DDX18 HLTF RBM5 PDCD11 DDX21 LCOR TOP2B | 3.20e-08 | 1294 | 112 | 19 | 30804502 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOLC1 CHERP MYO6 RSF1 NOC3L RFC1 NSRP1 ESF1 RIF1 SCML2 DST ALMS1 PRPF3 STAU2 DDX21 TOP2B | 5.53e-08 | 934 | 112 | 16 | 33916271 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NOLC1 AHCYL1 HK2 MYO6 RSF1 NOC3L MSH3 RFC1 ESF1 RIF1 TBC1D4 DST PRPF3 DDX18 HLTF PDCD11 PIP4K2C DDX21 TOP2B | 6.44e-08 | 1353 | 112 | 19 | 29467282 |
| Pubmed | IFT81 RSF1 DBT RFC1 SGO1 DST BBX ALMS1 ZNF608 PPIL2 PIP4K2C LCOR RAB5A | 1.73e-07 | 645 | 112 | 13 | 25281560 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 3.64e-07 | 283 | 112 | 9 | 30585729 | |
| Pubmed | 4.29e-07 | 210 | 112 | 8 | 16565220 | ||
| Pubmed | NOLC1 RSF1 PEX1 BUD13 DBT EZH1 RALGAPA2 NSRP1 ALMS1 ZNF608 BRDT CLU PRPF3 DDX18 PIP4K2C LCOR | 6.02e-07 | 1116 | 112 | 16 | 31753913 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 6.30e-07 | 394 | 112 | 10 | 27248496 | |
| Pubmed | 6.53e-07 | 222 | 112 | 8 | 37071664 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NOLC1 CHERP NOC3L RFC1 NSRP1 ESF1 RIF1 DDX18 HLTF RBM5 PDCD11 PPIL2 DDX21 RAB5A TOP2B | 6.96e-07 | 989 | 112 | 15 | 36424410 |
| Pubmed | NOLC1 AHCYL1 MYO6 NOC3L DBT RFC1 CIT RIF1 DST BBX ALMS1 ZNF608 DDX18 STAU2 AUTS2 PDCD11 PPIL2 YY1AP1 | 7.27e-07 | 1429 | 112 | 18 | 35140242 | |
| Pubmed | NRIP1 AHCYL1 VSNL1 MYO6 VPS45 IFT81 MSH3 ZNF227 CIT DST CLU DDX18 ROBO1 YY1AP1 STAMBPL1 CADPS2 LCOR | 7.85e-07 | 1285 | 112 | 17 | 35914814 | |
| Pubmed | DOCK4 HK2 MYO6 NOC3L MSH3 EZH1 DST PDCD11 PIP4K2C DDX21 LCOR TOP2B | 1.02e-06 | 634 | 112 | 12 | 34591612 | |
| Pubmed | HK2 CHERP MYO6 GTSE1 NUF2 MSH3 CIT ATAD1 DDX18 STAU2 HLTF PAM ADGRE5 STAMBPL1 DDX21 RPL3L | 1.09e-06 | 1168 | 112 | 16 | 19946888 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | NOLC1 RSF1 MSH3 RFC1 RIF1 SCML2 BBX BRDT DDX18 PIP4K2C TOP2B | 1.29e-06 | 533 | 112 | 11 | 30554943 |
| Pubmed | 1.63e-06 | 339 | 112 | 9 | 30415952 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | DOCK4 CASP8AP2 NRIP1 CNTLN SGO1 TBC1D4 ALMS1 SECISBP2 PPIL2 YY1AP1 PIP4K2C | 3.30e-06 | 588 | 112 | 11 | 38580884 |
| Pubmed | NOLC1 CASP8AP2 AHCYL1 MYO6 IFT81 NOC3L DBT NSRP1 ESF1 CLU DDX18 STAU2 PDCD11 ROBO1 DDX21 TOP3B TOP2B | 5.59e-06 | 1487 | 112 | 17 | 33957083 | |
| Pubmed | 5.85e-06 | 506 | 112 | 10 | 30890647 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | NOLC1 HK2 MYO6 PEX1 NUF2 DBT ESF1 DST ALMS1 ATAD1 DDX18 STAU2 PDCD11 SECISBP2 DDX21 METTL17 TOP3B | 6.05e-06 | 1496 | 112 | 17 | 32877691 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NOLC1 GTSE1 BUD13 RFC1 ATF2 ESF1 RIF1 SCML2 TBC1D4 YY1AP1 DDX21 TOP2B | 7.85e-06 | 774 | 112 | 12 | 15302935 |
| Pubmed | 8.51e-06 | 650 | 112 | 11 | 38777146 | ||
| Pubmed | NOLC1 CHERP RSF1 NOC3L RFC1 ESF1 RIF1 DST DDX18 PDCD11 DDX21 | 8.88e-06 | 653 | 112 | 11 | 22586326 | |
| Pubmed | 8.96e-06 | 86 | 112 | 5 | 37253089 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 31090963 | ||
| Pubmed | The Expression of NRIP1 and LCOR in Endometrioid Endometrial Cancer. | 1.03e-05 | 2 | 112 | 2 | 34410950 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 32157438 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 16769890 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 15451025 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 22012331 | ||
| Pubmed | Complex regulation of LCoR signaling in breast cancer cells. | 1.03e-05 | 2 | 112 | 2 | 28414308 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NOLC1 CHERP BUD13 DBT NSRP1 DST BBX PRPF3 DDX18 STAU2 RBM5 PPIL2 DDX21 TOP2B | 1.04e-05 | 1082 | 112 | 14 | 38697112 |
| Pubmed | 1.15e-05 | 14 | 112 | 3 | 21873192 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 1.22e-05 | 330 | 112 | 8 | 33301849 | |
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 1.25e-05 | 92 | 112 | 5 | 15840729 | |
| Pubmed | 1.33e-05 | 159 | 112 | 6 | 22751105 | ||
| Pubmed | Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus. | 1.33e-05 | 159 | 112 | 6 | 34578187 | |
| Pubmed | 1.78e-05 | 251 | 112 | 7 | 31076518 | ||
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 2.18e-05 | 259 | 112 | 7 | 30404004 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYH4 AHCYL1 MYO6 GTSE1 NOC3L DBT SCML2 ATAD1 PRPF3 RRN3 HLTF STAMBPL1 RPL3L | 2.20e-05 | 1005 | 112 | 13 | 19615732 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NOLC1 NRIP1 CHERP NOC3L DBT RFC1 MEIOC DDX18 STAU2 HLTF PDCD11 PIP4K2C DDX21 RAB5A TOP2B | 2.21e-05 | 1318 | 112 | 15 | 30463901 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MYO6 SCML2 RRN3 DDX18 STAU2 SECISBP2 PPIL2 DDX21 LCOR TOP3B TOP2B | 2.31e-05 | 724 | 112 | 11 | 36232890 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NRIP1 MCPH1 MYO6 VPS45 NSRP1 DNAH14 EHD3 TBC1D4 ZNF608 PRPF3 TTC12 RBM5 AUTS2 TNFAIP8 LCOR SLC4A5 | 2.32e-05 | 1489 | 112 | 16 | 28611215 |
| Pubmed | NOLC1 CASP8AP2 RSF1 MSH3 RFC1 ESF1 EHD2 RIF1 PRPF3 DDX18 NQO1 HLTF TOP2B | 2.41e-05 | 1014 | 112 | 13 | 32416067 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 2.72e-05 | 605 | 112 | 10 | 28977666 | |
| Pubmed | 2.77e-05 | 483 | 112 | 9 | 36912080 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 2.84e-05 | 608 | 112 | 10 | 36089195 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 30242288 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 21177873 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 26784654 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 30335157 | ||
| Pubmed | 3.79e-05 | 503 | 112 | 9 | 16964243 | ||
| Pubmed | 4.37e-05 | 777 | 112 | 11 | 35844135 | ||
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 4.45e-05 | 197 | 112 | 6 | 22365833 | |
| Pubmed | NOLC1 AHCYL1 MYO6 BUD13 DBT RFC1 CIT ESF1 TBC1D4 ZNF608 CLU DDX18 PPIL2 DDX21 | 4.91e-05 | 1247 | 112 | 14 | 27684187 | |
| Pubmed | 5.24e-05 | 63 | 112 | 4 | 25680957 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 5.25e-05 | 203 | 112 | 6 | 22083510 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NOLC1 MYO6 NOC3L BUD13 DBT RFC1 CIT ESF1 DST PRPF3 DDX18 STAU2 PDCD11 DDX21 | 5.35e-05 | 1257 | 112 | 14 | 36526897 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NOLC1 HK2 CHERP MYO6 NOC3L MSH3 DBT RFC1 ESF1 RIF1 DDX18 RBM5 PDCD11 DDX21 TOP2B | 5.39e-05 | 1425 | 112 | 15 | 30948266 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NOLC1 CHERP MYO6 GTSE1 NOC3L NSRP1 DST PRPF3 DDX18 PDCD11 PPIL2 DDX21 | 5.76e-05 | 949 | 112 | 12 | 36574265 |
| Pubmed | NOLC1 HK2 VPS45 GTSE1 NOC3L RFC1 EHD2 DST ATAD1 CLU PRPF3 STAU2 HLTF PDCD11 TOP2B | 6.06e-05 | 1440 | 112 | 15 | 30833792 | |
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 19033647 | ||
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 11062261 | ||
| Pubmed | C-terminal EH-domain-containing proteins: consensus for a role in endocytic trafficking, EH? | 6.14e-05 | 4 | 112 | 2 | 16155252 | |
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 17233914 | ||
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 10673336 | ||
| Pubmed | Rabenosyn-5 and EHD1 interact and sequentially regulate protein recycling to the plasma membrane. | 6.14e-05 | 4 | 112 | 2 | 15020713 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | NOLC1 CHERP NOC3L ESF1 PRPF3 DDX18 STAU2 RBM5 PDCD11 DDX21 TOP3B | 6.14e-05 | 807 | 112 | 11 | 22681889 |
| Pubmed | 6.17e-05 | 209 | 112 | 6 | 36779422 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | AHCYL1 GTSE1 CNTLN NSRP1 ALMS1 CLU DDX18 RBM5 PDCD11 METTL17 | 6.39e-05 | 670 | 112 | 10 | 22990118 |
| Pubmed | The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival. | 8.19e-05 | 220 | 112 | 6 | 31822558 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 8.40e-05 | 221 | 112 | 6 | 29991511 | |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 8.46e-05 | 321 | 112 | 7 | 32098917 | |
| Pubmed | 9.27e-05 | 225 | 112 | 6 | 12168954 | ||
| Pubmed | GGNBP2 CHERP NOC3L RFC1 RIF1 PRPF3 DDX18 RBM5 PDCD11 DDX21 TOP2B | 9.43e-05 | 847 | 112 | 11 | 35850772 | |
| Pubmed | 9.61e-05 | 568 | 112 | 9 | 9110174 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 9.90e-05 | 444 | 112 | 8 | 34795231 | |
| Pubmed | EH domain proteins regulate cardiac membrane protein targeting. | 1.02e-04 | 5 | 112 | 2 | 20489164 | |
| Pubmed | 1.02e-04 | 5 | 112 | 2 | 33037408 | ||
| Pubmed | 1.02e-04 | 5 | 112 | 2 | 36002265 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 1.04e-04 | 857 | 112 | 11 | 25609649 | |
| Pubmed | 1.05e-04 | 230 | 112 | 6 | 35449600 | ||
| Pubmed | 1.10e-04 | 335 | 112 | 7 | 15741177 | ||
| Pubmed | Global analysis of gene expression in the developing brain of Gtf2ird1 knockout mice. | 1.12e-04 | 29 | 112 | 3 | 21909369 | |
| Pubmed | Raftlin is involved in the nucleocapture complex to induce poly(I:C)-mediated TLR3 activation. | 1.12e-04 | 29 | 112 | 3 | 21266579 | |
| Pubmed | 1.19e-04 | 723 | 112 | 10 | 34133714 | ||
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 1.21e-04 | 148 | 112 | 5 | 32538781 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | 1.32e-04 | 732 | 112 | 10 | 34732716 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 1.42e-04 | 349 | 112 | 7 | 25665578 | |
| Pubmed | 1.44e-04 | 469 | 112 | 8 | 27634302 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 1.46e-04 | 154 | 112 | 5 | 16055720 | |
| Pubmed | 1.53e-04 | 6 | 112 | 2 | 22768111 | ||
| Pubmed | Divalent Rab effectors regulate the sub-compartmental organization and sorting of early endosomes. | 1.53e-04 | 6 | 112 | 2 | 11788822 | |
| Pubmed | 1.83e-04 | 486 | 112 | 8 | 20936779 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 1.83e-04 | 486 | 112 | 8 | 30940648 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 1.84e-04 | 364 | 112 | 7 | 24778252 | |
| Pubmed | 2.11e-04 | 496 | 112 | 8 | 31343991 | ||
| Interaction | H1-4 interactions | NOLC1 CHERP RSF1 NOC3L BUD13 RFC1 CIT PYHIN1 TBC1D4 BBX DDX18 STAU2 PDCD11 DDX21 FER1L5 METTL17 LCOR TOP2B ALPK2 | 3.51e-09 | 656 | 112 | 19 | int:H1-4 |
| Interaction | DDX23 interactions | NOLC1 CHERP NOC3L BUD13 CIT NSRP1 ESF1 BRDT PRPF3 DDX18 RBM5 PDCD11 PPIL2 PIP4K2C DDX21 TOP2B | 9.75e-09 | 480 | 112 | 16 | int:DDX23 |
| Interaction | SNRNP40 interactions | CASP8AP2 CHERP RSF1 NOC3L BUD13 RFC1 CIT ZNF608 PRPF3 DDX18 HLTF RBM5 PDCD11 PPIL2 DDX21 TOP3B TOP2B | 8.35e-08 | 637 | 112 | 17 | int:SNRNP40 |
| Interaction | POLR1G interactions | NOLC1 RSF1 NOC3L BUD13 RFC1 CIT ESF1 BBX RRN3 DDX18 PDCD11 PPIL2 DDX21 LCOR TOP2B | 8.72e-08 | 489 | 112 | 15 | int:POLR1G |
| Interaction | ZNF330 interactions | NOLC1 RSF1 NOC3L MSH3 RFC1 ESF1 BBX DDX18 HLTF PDCD11 PPIL2 DDX21 LCOR TOP2B | 1.84e-07 | 446 | 112 | 14 | int:ZNF330 |
| Interaction | CIT interactions | NOLC1 NRIP1 CHERP MYO6 RSF1 NOC3L NUF2 RALGAPA2 CIT ESF1 PYHIN1 RIF1 ALMS1 ATAD1 PRPF3 DDX18 HLTF RBM5 PDCD11 SECISBP2 DDX21 RPL3L TOP3B RAB5A TOP2B | 2.94e-07 | 1450 | 112 | 25 | int:CIT |
| Interaction | NUP43 interactions | CASP8AP2 RSF1 NOC3L BUD13 RFC1 SGO1 CIT RIF1 DST BBX ZNF608 DDX18 HLTF PDCD11 LCOR TOP2B | 3.64e-07 | 625 | 112 | 16 | int:NUP43 |
| Interaction | SMC5 interactions | NOLC1 MYH4 CHERP GTSE1 RSF1 NOC3L BUD13 RFC1 NSRP1 ESF1 RIF1 SCML2 BBX PRPF3 DDX18 STAU2 PDCD11 DDX21 LCOR TOP2B | 5.74e-07 | 1000 | 112 | 20 | int:SMC5 |
| Interaction | BRD2 interactions | NOLC1 RSF1 RFC1 EZH1 RIF1 BRDT PRPF3 DDX18 AUTS2 PIP4K2C LCOR TOP3B TOP2B | 7.74e-07 | 429 | 112 | 13 | int:BRD2 |
| Interaction | RPL31 interactions | NOLC1 CHERP NOC3L BUD13 RFC1 CIT ESF1 BBX PRPF3 DDX18 STAU2 PDCD11 PPIL2 DDX21 METTL17 TOP2B | 1.11e-06 | 680 | 112 | 16 | int:RPL31 |
| Interaction | CENPA interactions | RSF1 NOC3L MSH3 RFC1 ESF1 BBX DDX18 HLTF PDCD11 PPIL2 LCOR TOP2B | 1.27e-06 | 377 | 112 | 12 | int:CENPA |
| Interaction | FBL interactions | NOLC1 NOC3L RFC1 CIT ESF1 PRPF3 DDX18 STAU2 PDCD11 SECISBP2 YY1AP1 DDX21 TOP3B RAB5A TOP2B | 2.55e-06 | 639 | 112 | 15 | int:FBL |
| Interaction | CBX3 interactions | RSF1 ZNF227 RFC1 EZH1 SGO1 CIT NSRP1 ESF1 RIF1 SCML2 BBX PRPF3 PPIL2 LCOR TOP2B | 2.91e-06 | 646 | 112 | 15 | int:CBX3 |
| Interaction | BRD3 interactions | NOLC1 RSF1 BUD13 MSH3 RFC1 CIT RIF1 SCML2 BBX PRPF3 DDX18 PIP4K2C TOP2B | 3.68e-06 | 494 | 112 | 13 | int:BRD3 |
| Interaction | SURF6 interactions | MYO6 NOC3L BUD13 DBT RFC1 ESF1 BBX DDX18 STAU2 PDCD11 DDX21 TOP3B | 4.48e-06 | 426 | 112 | 12 | int:SURF6 |
| Interaction | NIFK interactions | NOLC1 NOC3L BUD13 RFC1 CIT ESF1 BBX DDX18 STAU2 PDCD11 DDX21 TOP2B | 5.04e-06 | 431 | 112 | 12 | int:NIFK |
| Interaction | OBSL1 interactions | NOLC1 GGNBP2 CHERP MCPH1 RFC1 CIT IQCA1L RIF1 DST PRPF3 DDX18 STAU2 PDCD11 POLQ DDX21 TOP2B ALPK2 | 9.82e-06 | 902 | 112 | 17 | int:OBSL1 |
| Interaction | FGFBP1 interactions | 1.36e-05 | 257 | 112 | 9 | int:FGFBP1 | |
| Interaction | UHRF2 interactions | 1.61e-05 | 200 | 112 | 8 | int:UHRF2 | |
| Interaction | ZNF827 interactions | 1.93e-05 | 29 | 112 | 4 | int:ZNF827 | |
| Interaction | MACROH2A2 interactions | 2.37e-05 | 211 | 112 | 8 | int:MACROH2A2 | |
| Interaction | NEIL1 interactions | 2.39e-05 | 276 | 112 | 9 | int:NEIL1 | |
| Interaction | MAGEB2 interactions | 2.53e-05 | 349 | 112 | 10 | int:MAGEB2 | |
| Interaction | POLR1E interactions | 2.59e-05 | 350 | 112 | 10 | int:POLR1E | |
| Interaction | RPS6 interactions | NOLC1 RSF1 NOC3L BUD13 RFC1 CIT ESF1 PYHIN1 BBX PRPF3 DDX18 STAU2 PDCD11 DDX21 RPL3L TOP2B | 2.63e-05 | 874 | 112 | 16 | int:RPS6 |
| Interaction | NAA40 interactions | NOLC1 CHERP MYO6 RSF1 NOC3L RFC1 CIT NSRP1 ESF1 RIF1 SCML2 DST ALMS1 PRPF3 STAU2 DDX21 TOP2B | 2.77e-05 | 978 | 112 | 17 | int:NAA40 |
| Interaction | HECTD1 interactions | NOLC1 NRIP1 AHCYL1 NOC3L BUD13 DBT RFC1 ESF1 RIF1 PRPF3 DDX18 STAU2 PDCD11 DDX21 METTL17 TOP3B TOP2B | 3.00e-05 | 984 | 112 | 17 | int:HECTD1 |
| Interaction | FGF8 interactions | 3.11e-05 | 108 | 112 | 6 | int:FGF8 | |
| Interaction | RPL23A interactions | NOLC1 NOC3L CIT NSRP1 PYHIN1 IGSF10 DST DDX18 STAU2 PDCD11 DDX21 METTL17 RPL3L | 3.22e-05 | 606 | 112 | 13 | int:RPL23A |
| Interaction | SPOUT1 interactions | 3.54e-05 | 163 | 112 | 7 | int:SPOUT1 | |
| Interaction | GTPBP4 interactions | MYO6 NOC3L EZH1 CIT NSRP1 ESF1 PYHIN1 DDX18 PDCD11 DDX21 RAB5A | 3.66e-05 | 443 | 112 | 11 | int:GTPBP4 |
| Interaction | DHX8 interactions | 3.71e-05 | 292 | 112 | 9 | int:DHX8 | |
| Interaction | RPL18A interactions | NOLC1 NOC3L RFC1 CIT NEDD4 BBX DDX18 PDCD11 DDX21 RPL3L RAB5A | 3.97e-05 | 447 | 112 | 11 | int:RPL18A |
| Interaction | DNAJC9 interactions | 4.13e-05 | 296 | 112 | 9 | int:DNAJC9 | |
| Interaction | SRPK2 interactions | NOLC1 AHCYL1 CHERP NOC3L BUD13 NSRP1 PYHIN1 ALMS1 CLU DDX18 PDCD11 CADPS2 DDX21 TOP2B | 4.39e-05 | 717 | 112 | 14 | int:SRPK2 |
| Interaction | LYAR interactions | 4.43e-05 | 373 | 112 | 10 | int:LYAR | |
| Interaction | FGF13 interactions | 4.88e-05 | 117 | 112 | 6 | int:FGF13 | |
| Interaction | SCARNA22 interactions | 5.12e-05 | 118 | 112 | 6 | int:SCARNA22 | |
| Interaction | COIL interactions | NOLC1 CASP8AP2 MSH3 CIT ESF1 BBX PRPF3 DDX18 HLTF PDCD11 PPIL2 TOP2B | 5.81e-05 | 552 | 112 | 12 | int:COIL |
| Interaction | PDS5A interactions | 6.82e-05 | 245 | 112 | 8 | int:PDS5A | |
| Interaction | DCAF13 interactions | 7.22e-05 | 247 | 112 | 8 | int:DCAF13 | |
| Interaction | NOP56 interactions | NOLC1 NOC3L BUD13 RFC1 CIT ESF1 BRDT PRPF3 DDX18 PDCD11 DDX21 TOP2B | 7.88e-05 | 570 | 112 | 12 | int:NOP56 |
| Interaction | MECP2 interactions | NOLC1 CHERP BUD13 DBT EZH1 NSRP1 ESF1 PYHIN1 DST BBX PRPF3 DDX18 STAU2 RBM5 PDCD11 PPIL2 DDX21 METTL17 TOP2B | 8.28e-05 | 1287 | 112 | 19 | int:MECP2 |
| Interaction | H2BC8 interactions | RSF1 BUD13 MSH3 RFC1 SGO1 NSRP1 ESF1 RIF1 SCML2 BBX PPIL2 TOP2B | 8.70e-05 | 576 | 112 | 12 | int:H2BC8 |
| Interaction | ADARB1 interactions | NOC3L BUD13 RFC1 SCML2 BBX PRPF3 STAU2 PDCD11 ADGRE5 DDX21 TOP2B | 8.87e-05 | 489 | 112 | 11 | int:ADARB1 |
| Interaction | ATM interactions | 1.02e-04 | 333 | 112 | 9 | int:ATM | |
| Interaction | RPL13A interactions | NOC3L BUD13 CIT NSRP1 BBX PRPF3 DDX18 STAU2 PDCD11 DDX21 TOP3B RAB5A | 1.11e-04 | 591 | 112 | 12 | int:RPL13A |
| Interaction | SNIP1 interactions | 1.12e-04 | 417 | 112 | 10 | int:SNIP1 | |
| Interaction | SMC1A interactions | 1.14e-04 | 418 | 112 | 10 | int:SMC1A | |
| Interaction | PHIP interactions | 1.17e-04 | 197 | 112 | 7 | int:PHIP | |
| Interaction | H3C1 interactions | CHERP MYO6 RSF1 NOC3L MSH3 RFC1 NSRP1 RIF1 BBX PRPF3 DDX18 PPIL2 LCOR TOP3B TOP2B | 1.39e-04 | 901 | 112 | 15 | int:H3C1 |
| Interaction | ANOS1 interactions | 1.48e-04 | 143 | 112 | 6 | int:ANOS1 | |
| Interaction | SP100 interactions | 1.54e-04 | 206 | 112 | 7 | int:SP100 | |
| Interaction | C6orf141 interactions | 1.62e-04 | 92 | 112 | 5 | int:C6orf141 | |
| Interaction | EZH1 interactions | 1.62e-04 | 92 | 112 | 5 | int:EZH1 | |
| Interaction | TNFRSF1B interactions | 1.66e-04 | 146 | 112 | 6 | int:TNFRSF1B | |
| Interaction | ARL4D interactions | 1.66e-04 | 146 | 112 | 6 | int:ARL4D | |
| Interaction | BRCA1 interactions | DOCK4 NOLC1 NRIP1 HK2 MCPH1 MSH3 CNTLN RFC1 CIT ATF2 RIF1 NMI DST ALMS1 PRPF3 HLTF DDX21 TOP2B | 1.76e-04 | 1249 | 112 | 18 | int:BRCA1 |
| Interaction | KIF27 interactions | 1.78e-04 | 20 | 112 | 3 | int:KIF27 | |
| Interaction | RBM23 interactions | 1.79e-04 | 94 | 112 | 5 | int:RBM23 | |
| Interaction | XRCC6 interactions | RFC1 SGO1 CIT ESF1 PYHIN1 RIF1 SCML2 NMI BBX CLU PRPF3 PPIL2 DDX21 TOP3B TOP2B | 1.91e-04 | 928 | 112 | 15 | int:XRCC6 |
| Interaction | CHD4 interactions | NOLC1 CHERP MCPH1 RSF1 NOC3L RFC1 CIT PYHIN1 NMI PRPF3 DDX18 RBM5 PDCD11 DDX21 TOP2B | 2.15e-04 | 938 | 112 | 15 | int:CHD4 |
| Interaction | APEX1 interactions | NOLC1 MYO6 PARP8 RSF1 NOC3L BUD13 RFC1 ATF2 NSRP1 DNAH14 NEDD4 RIF1 SCML2 BBX PDCD11 METTL17 LCOR TOP2B | 2.18e-04 | 1271 | 112 | 18 | int:APEX1 |
| Interaction | RPL19 interactions | NOLC1 CHERP NOC3L BUD13 CIT PYHIN1 DDX18 STAU2 RBM5 DDX21 METTL17 RPL3L | 2.25e-04 | 638 | 112 | 12 | int:RPL19 |
| Interaction | MFAP1 interactions | 2.44e-04 | 295 | 112 | 8 | int:MFAP1 | |
| Interaction | KPNA4 interactions | 2.64e-04 | 225 | 112 | 7 | int:KPNA4 | |
| Interaction | PRPF38A interactions | 2.82e-04 | 161 | 112 | 6 | int:PRPF38A | |
| Interaction | HDDC3 interactions | 2.85e-04 | 57 | 112 | 4 | int:HDDC3 | |
| Interaction | MAST1 interactions | 2.87e-04 | 228 | 112 | 7 | int:MAST1 | |
| Interaction | GNL2 interactions | 3.06e-04 | 386 | 112 | 9 | int:GNL2 | |
| Interaction | RPLP0 interactions | CHERP NOC3L BUD13 CIT NSRP1 BBX DDX18 STAU2 PDCD11 DDX21 RPL3L RAB5A | 3.07e-04 | 660 | 112 | 12 | int:RPLP0 |
| Interaction | GAR1 interactions | 3.18e-04 | 232 | 112 | 7 | int:GAR1 | |
| Interaction | GPATCH4 interactions | 3.18e-04 | 232 | 112 | 7 | int:GPATCH4 | |
| Interaction | NDC80 interactions | 3.56e-04 | 312 | 112 | 8 | int:NDC80 | |
| Interaction | HUNK interactions | 3.58e-04 | 109 | 112 | 5 | int:HUNK | |
| Interaction | EED interactions | NOLC1 HK2 MYO6 VPS45 NOC3L PEX1 MSH3 DBT EZH1 CIT NEDD4 RIF1 DDX18 RBM5 PDCD11 PIP4K2C DDX21 LCOR RAB5A | 3.67e-04 | 1445 | 112 | 19 | int:EED |
| Interaction | SART1 interactions | 3.96e-04 | 317 | 112 | 8 | int:SART1 | |
| Interaction | POU5F1 interactions | 4.11e-04 | 584 | 112 | 11 | int:POU5F1 | |
| Interaction | RHOV interactions | 4.21e-04 | 243 | 112 | 7 | int:RHOV | |
| Interaction | RPL28 interactions | 4.34e-04 | 494 | 112 | 10 | int:RPL28 | |
| Interaction | ARGLU1 interactions | 4.54e-04 | 176 | 112 | 6 | int:ARGLU1 | |
| Interaction | RBSN interactions | 4.71e-04 | 65 | 112 | 4 | int:RBSN | |
| Interaction | KPNA3 interactions | 4.75e-04 | 248 | 112 | 7 | int:KPNA3 | |
| Interaction | LILRB4 interactions | 4.95e-04 | 28 | 112 | 3 | int:LILRB4 | |
| Interaction | FGF3 interactions | 5.00e-04 | 66 | 112 | 4 | int:FGF3 | |
| Interaction | TOM1L2 interactions | 5.00e-04 | 66 | 112 | 4 | int:TOM1L2 | |
| Interaction | SRSF6 interactions | 5.00e-04 | 503 | 112 | 10 | int:SRSF6 | |
| Interaction | RPL36 interactions | 5.07e-04 | 504 | 112 | 10 | int:RPL36 | |
| Interaction | USP36 interactions | DOCK4 NOLC1 MYO6 NOC3L RFC1 ESF1 NEDD4 RIF1 DDX18 PDCD11 DDX21 | 5.08e-04 | 599 | 112 | 11 | int:USP36 |
| Interaction | RANBP10 interactions | 5.15e-04 | 118 | 112 | 5 | int:RANBP10 | |
| Interaction | H2AC4 interactions | 5.23e-04 | 506 | 112 | 10 | int:H2AC4 | |
| Interaction | NOP2 interactions | 5.27e-04 | 416 | 112 | 9 | int:NOP2 | |
| Interaction | ESF1 interactions | 5.42e-04 | 182 | 112 | 6 | int:ESF1 | |
| Interaction | MEN1 interactions | NOLC1 CHERP NOC3L RFC1 ATF2 RIF1 SCML2 ZNF608 PRPF3 DDX18 RBM5 PDCD11 YY1AP1 DDX21 TOP2B | 5.71e-04 | 1029 | 112 | 15 | int:MEN1 |
| Interaction | PLCD3 interactions | 5.77e-04 | 121 | 112 | 5 | int:PLCD3 | |
| Interaction | KIF23 interactions | NOLC1 CHERP RSF1 NOC3L RFC1 RALGAPA2 CIT ALMS1 DDX18 STAU2 PDCD11 DDX21 TOP3B RAB5A TOP2B | 5.82e-04 | 1031 | 112 | 15 | int:KIF23 |
| Interaction | HNRNPU interactions | NOC3L DBT RFC1 CIT NSRP1 ESF1 NEDD4 NMI DDX18 STAU2 PDCD11 DDX21 TOP3B RAB5A HYDIN | 6.06e-04 | 1035 | 112 | 15 | int:HNRNPU |
| Interaction | G3BP2 interactions | NOLC1 CIT NSRP1 PYHIN1 DDX18 DDX21 METTL17 RPL3L TOP3B TOP2B | 6.27e-04 | 518 | 112 | 10 | int:G3BP2 |
| Interaction | CFAP43 interactions | 6.31e-04 | 7 | 112 | 2 | int:CFAP43 | |
| Interaction | SLC45A1 interactions | 6.31e-04 | 7 | 112 | 2 | int:SLC45A1 | |
| Cytoband | 2p13 | 2.42e-05 | 23 | 112 | 3 | 2p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q23 | 3.03e-04 | 53 | 112 | 3 | chr2q23 | |
| GeneFamily | Topoisomerases | 1.35e-04 | 6 | 55 | 2 | 1050 | |
| GeneFamily | AAA ATPases | 5.60e-04 | 53 | 55 | 3 | 413 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 2.02e-03 | 22 | 55 | 2 | 579 | |
| GeneFamily | EF-hand domain containing | 4.41e-03 | 219 | 55 | 4 | 863 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CASP8AP2 NRIP1 GGNBP2 MYO6 RSF1 NOC3L NUF2 MSH3 RFC1 NSRP1 ESF1 RIF1 NMI BBX HLTF POLQ DDX21 TOP2B | 3.74e-10 | 656 | 112 | 18 | M18979 |
| Coexpression | GSE20366_TREG_VS_TCONV_DN | 2.41e-06 | 200 | 112 | 8 | M4312 | |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | 5.90e-06 | 568 | 112 | 12 | M4023 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | CASP8AP2 AHCYL1 GTSE1 BUD13 NUF2 MSH3 CNTLN SGO1 CIT RIF1 KATNBL1 ALMS1 HLTF AUTS2 POLQ | 1.13e-05 | 939 | 112 | 15 | M45768 |
| Coexpression | FISCHER_DREAM_TARGETS | NOLC1 CASP8AP2 GTSE1 NOC3L NUF2 MSH3 RFC1 SGO1 CIT ATF2 RIF1 ALMS1 HLTF POLQ DDX21 | 1.63e-05 | 969 | 112 | 15 | M149 |
| Coexpression | GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP | 2.50e-05 | 200 | 112 | 7 | M7898 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | 3.72e-05 | 474 | 112 | 10 | M40991 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | GGNBP2 PARP8 RSF1 RALGAPA2 KATNBL1 TBC1D4 BBX PER3 ALMS1 CLU RBM5 TNFAIP8 SLC4A4 | 4.17e-05 | 807 | 112 | 13 | M16651 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 4.56e-05 | 300 | 112 | 8 | M8702 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP | NOLC1 ZNF789 VPS45 NOC3L PEX1 ESF1 NEDD4 TBC1D4 ALMS1 NQO1 PDCD11 ZSCAN16 FAM118A DDX21 | 4.98e-05 | 942 | 112 | 14 | M8144 |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_DN | 1.24e-04 | 258 | 112 | 7 | M2446 | |
| Coexpression | LEE_BMP2_TARGETS_DN | NOLC1 CASP8AP2 HK2 NOC3L SGO1 ESF1 RIF1 RRN3 DDX18 PDCD11 SECISBP2 TNFAIP8 DDX21 | 1.31e-04 | 904 | 112 | 13 | M2325 |
| Coexpression | LEE_BMP2_TARGETS_DN | NOLC1 CASP8AP2 HK2 NOC3L SGO1 ESF1 RIF1 RRN3 DDX18 PDCD11 SECISBP2 TNFAIP8 DDX21 | 1.58e-04 | 922 | 112 | 13 | MM1068 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | DOCK4 GGNBP2 MCPH1 RFC1 RALGAPA2 RIF1 BBX PRPF3 RRN3 STAMBPL1 LCOR | 1.62e-04 | 680 | 112 | 11 | M41089 |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_UP | 1.65e-04 | 189 | 112 | 6 | M9978 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_DN | 1.68e-04 | 271 | 112 | 7 | MM1075 | |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | CASP8AP2 NRIP1 NOC3L ATF2 ESF1 TBC1D4 ATAD1 DDX18 HLTF STAMBPL1 TNFAIP8 | 1.77e-04 | 687 | 112 | 11 | M41022 |
| Coexpression | GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_UP | 1.95e-04 | 195 | 112 | 6 | M3319 | |
| Coexpression | GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN | 2.01e-04 | 196 | 112 | 6 | M7551 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN | 2.12e-04 | 198 | 112 | 6 | M5419 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | 2.16e-04 | 478 | 112 | 9 | M45785 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP | 2.18e-04 | 199 | 112 | 6 | M9320 | |
| Coexpression | GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP | 2.18e-04 | 199 | 112 | 6 | M9566 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_DN | 2.18e-04 | 199 | 112 | 6 | M3795 | |
| Coexpression | GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP | 2.24e-04 | 200 | 112 | 6 | M8090 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_DN | 2.24e-04 | 200 | 112 | 6 | M3742 | |
| Coexpression | GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP | 2.24e-04 | 200 | 112 | 6 | M7525 | |
| Coexpression | GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_DN | 2.24e-04 | 200 | 112 | 6 | M8867 | |
| Coexpression | GSE34515_CD16_POS_MONOCYTE_VS_DC_UP | 2.24e-04 | 200 | 112 | 6 | M8765 | |
| Coexpression | BENPORATH_ES_1 | 2.28e-04 | 379 | 112 | 8 | M1871 | |
| Coexpression | TBK1.DF_DN | 2.34e-04 | 286 | 112 | 7 | M2864 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | NOLC1 CASP8AP2 MCPH1 GTSE1 NUF2 MSH3 SGO1 CIT ALMS1 HLTF POLQ | 2.46e-04 | 714 | 112 | 11 | M1744 |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING | 2.74e-04 | 73 | 112 | 4 | MM3841 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | DOCK4 KANSL1L NRIP1 GGNBP2 RFC1 EZH1 ESF1 RIF1 SCML2 KATNBL1 BBX PER3 MEIOC BRDT CLU RBM5 LCOR NOBOX | 9.83e-08 | 778 | 110 | 18 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.52e-07 | 182 | 110 | 9 | gudmap_developingGonad_e16.5_ovary_1000_k1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | NOLC1 KANSL1L CASP8AP2 CUX2 HK2 IFT81 RSF1 MSH3 CNTLN SGO1 TDRD1 CIT NSRP1 ESF1 IGSF10 RIF1 ALMS1 NQO1 SLC4A4 TOP2B | 5.28e-06 | 1241 | 110 | 20 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | DOCK4 NRIP1 GGNBP2 VSNL1 ESF1 RIF1 SCML2 KATNBL1 BBX PER3 ALMS1 MEIOC BRDT RBM5 LCOR | 1.13e-05 | 776 | 110 | 15 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | DOCK4 NRIP1 GGNBP2 VSNL1 ESF1 RIF1 SCML2 KATNBL1 BBX MEIOC BRDT CLU STAU2 RBM5 LCOR | 1.50e-05 | 795 | 110 | 15 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | MCPH1 RFC1 EZH1 RIF1 SCML2 KATNBL1 BBX PER3 BRDT CLU STAU2 RBM5 LCOR NOBOX | 4.42e-05 | 770 | 110 | 14 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | NOLC1 KANSL1L CASP8AP2 CUX2 HK2 IFT81 RSF1 MSH3 CNTLN SGO1 TDRD1 CIT NSRP1 ESF1 IGSF10 RIF1 ALMS1 NQO1 SLC4A4 TOP2B | 5.95e-05 | 1468 | 110 | 20 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.10e-05 | 334 | 110 | 9 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 6.43e-05 | 192 | 110 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | NOLC1 CASP8AP2 CUX2 HK2 MCPH1 RSF1 MSH3 RFC1 SGO1 ESF1 RIF1 BBX ALMS1 ZNF608 DDX18 TTC12 ROBO1 CADPS2 SLC4A5 | 7.47e-05 | 1371 | 110 | 19 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | NOC3L TDRD1 NSRP1 ESF1 RIF1 SCML2 BBX ALMS1 BRDT PRPF3 DDX18 HLTF PDCD11 DDX21 | 7.61e-05 | 810 | 110 | 14 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | AHCYL1 CUX2 KIF26B ENPP1 GAS2 RSF1 MSH3 ATF2 RIF1 ROBO1 TNFAIP8 SLC4A4 LCOR TOP2B | 8.45e-05 | 818 | 110 | 14 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | GAS2 NUF2 ZNF227 CNTLN SGO1 GALNT13 PER3 ATAD1 MEIOC SLC16A2 HLTF STAMBPL1 CADPS2 TOP2B | 8.56e-05 | 819 | 110 | 14 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | KIF26B GAS2 RSF1 GALNT13 CABLES1 RIF1 SCML2 DST AUTS2 ROBO1 STAMBPL1 TNFAIP8 LCOR TOP2B | 1.06e-04 | 836 | 110 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.64e-04 | 469 | 110 | 10 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | 1.69e-04 | 382 | 110 | 9 | gudmap_developingGonad_e14.5_ ovary_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | NRIP1 AHCYL1 CUX2 MYO6 PEX1 MSH3 EZH1 PER3 HLTF SLC4A4 CADPS2 LCOR TOP2B | 1.85e-04 | 774 | 110 | 13 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | 1.86e-04 | 387 | 110 | 9 | gudmap_developingGonad_e16.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.87e-04 | 160 | 110 | 6 | gudmap_developingGonad_e18.5_ovary_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | NOLC1 KIF26B PARP8 NOC3L PEX1 MSH3 EZH1 RIF1 TBC1D4 ATAD1 DDX18 HLTF TOP2B | 1.97e-04 | 779 | 110 | 13 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.18e-04 | 311 | 110 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | NOLC1 NOC3L NUF2 ESF1 RIF1 SCML2 ALMS1 BRDT RRN3 DDX18 HLTF PDCD11 DDX21 | 2.40e-04 | 795 | 110 | 13 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | KIF26B RSF1 GALNT13 CABLES1 RIF1 SCML2 AUTS2 ROBO1 STAMBPL1 TNFAIP8 | 2.41e-04 | 492 | 110 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | DOCK4 UBTD2 VSNL1 KIF26B ENPP1 IFT81 CNTLN IGSF10 CLU PAM TNFAIP8 SLC4A4 DSEL | 2.46e-04 | 797 | 110 | 13 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | DOCK4 NRIP1 GGNBP2 RSF1 RFC1 ESF1 RIF1 SCML2 KATNBL1 BBX BRDT RBM5 LCOR | 2.74e-04 | 806 | 110 | 13 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | 2.80e-04 | 409 | 110 | 9 | GSM399452_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | 2.80e-04 | 409 | 110 | 9 | gudmap_developingGonad_e12.5_ovary_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500 | 3.20e-04 | 249 | 110 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 4.30e-04 | 68 | 110 | 4 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.30e-04 | 68 | 110 | 4 | gudmap_developingGonad_e16.5_testes_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.06e-04 | 126 | 110 | 5 | gudmap_developingGonad_e14.5_ ovary_1000_k2 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | CUX2 MYO6 KIF26B PARP8 GAS2 SGO1 ALMS1 ZNF608 CLU STAU2 ROBO1 CADPS2 | 5.06e-04 | 749 | 110 | 12 | gudmap_kidney_P3_CapMes_Crym_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | KANSL1L KIF26B ENPP1 GAS2 CNTLN PYHIN1 IGSF10 NMI CLU SLC16A2 STAU2 ADGRE5 TNFAIP8 | 6.17e-04 | 878 | 110 | 13 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | AHCYL1 CUX2 KIF26B ENPP1 MSH3 CABLES1 RIF1 DST HLTF AUTS2 ROBO1 STAMBPL1 | 6.39e-04 | 769 | 110 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.85e-04 | 463 | 110 | 9 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.15e-04 | 136 | 110 | 5 | gudmap_developingGonad_e14.5_ testes_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.15e-04 | 136 | 110 | 5 | gudmap_developingGonad_P2_epididymis_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.52e-04 | 375 | 110 | 8 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | 8.06e-04 | 379 | 110 | 8 | gudmap_developingGonad_P2_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.42e-04 | 141 | 110 | 5 | gudmap_developingGonad_P2_ovary_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | CHERP KIF26B GALNT13 CABLES1 RIF1 SCML2 AUTS2 ROBO1 STAMBPL1 | 8.58e-04 | 478 | 110 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5 |
| CoexpressionAtlas | Pluripotent Stem Cells_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | NOLC1 VSNL1 HK2 ENPP1 PARP8 RIF1 TBC1D4 CLU SLC16A2 NQO1 ROBO1 CADPS2 | 8.63e-04 | 796 | 110 | 12 | PCBC_ratio_SC_vs_MESO-5_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | NRIP1 GGNBP2 MYO6 ENPP1 ATF2 ESF1 RIF1 SCML2 KATNBL1 CLU RBM5 LCOR | 8.72e-04 | 797 | 110 | 12 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | 9.22e-04 | 387 | 110 | 8 | gudmap_developingGonad_e18.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | DOCK4 NRIP1 GGNBP2 VSNL1 RFC1 CIT ESF1 RIF1 SCML2 KATNBL1 RBM5 LCOR | 9.41e-04 | 804 | 110 | 12 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#4 | 9.52e-04 | 587 | 110 | 10 | Facebase_RNAseq_e8.5_Floor Plate_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | KANSL1L KIF26B GAS2 CNTLN PYHIN1 IGSF10 SLC16A2 STAU2 ADGRE5 TNFAIP8 | 1.00e-03 | 591 | 110 | 10 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_200 | 1.01e-03 | 147 | 110 | 5 | gudmap_developingGonad_e18.5_ovary_200 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 6.81e-07 | 197 | 112 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-CD4+_CTL|Int-URO / Disease, condition lineage and cell class | 7.05e-07 | 198 | 112 | 7 | 717735d755745439f97ba1b71785c73945dfa9c5 | |
| ToppCell | COVID-19-COVID-19_Severe-Others-HSPC|COVID-19_Severe / Disease, condition lineage and cell class | 7.29e-07 | 199 | 112 | 7 | 25de67b6c9c8d6bb9a538e071a40ef865906c95d | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 7.29e-07 | 199 | 112 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.73e-06 | 171 | 112 | 6 | 4ede6e916e593f208f2f8ccf82ef2335e061fc86 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.89e-06 | 172 | 112 | 6 | e9b97f37bb1732ad9aa89c5e9b513d14022801ac | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-Cycling_Dendritic|Lung / Manually curated celltypes from each tissue | 5.06e-06 | 173 | 112 | 6 | 62e0c18cfed9645e34a9d7029c94a8554f773714 | |
| ToppCell | IIH-Treg-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 6.77e-06 | 182 | 112 | 6 | 5c7d02da9ca2bca49db9832704b6894dfaa08a71 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-06 | 184 | 112 | 6 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.14e-06 | 188 | 112 | 6 | ecc2364d946f97ae0212fd6739960c9fc75e4919 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 188 | 112 | 6 | e079a3873cf442e98ff41a240c80b80995aace11 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.39e-06 | 189 | 112 | 6 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 8.65e-06 | 190 | 112 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.91e-06 | 191 | 112 | 6 | d7920f4a602b50d0ef064eb47001e71939695ed2 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.91e-06 | 191 | 112 | 6 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.74e-06 | 194 | 112 | 6 | c197e4acbff42a9f0410b6801c2bfcf6160aefc1 | |
| ToppCell | BL-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.74e-06 | 194 | 112 | 6 | 2932f704656ca368565ec12f3452af3b18e8df12 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.74e-06 | 194 | 112 | 6 | 8985095f291c1b54e45f4edece49aa26e8c8b732 | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 1.00e-05 | 195 | 112 | 6 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 195 | 112 | 6 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 1.03e-05 | 196 | 112 | 6 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.03e-05 | 196 | 112 | 6 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 1.03e-05 | 196 | 112 | 6 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.03e-05 | 196 | 112 | 6 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-05 | 197 | 112 | 6 | cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 198 | 112 | 6 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-05 | 198 | 112 | 6 | 8aa4149d2c1cec73cfd654db093252ec8ec5ef68 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 198 | 112 | 6 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | mLN-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 1.13e-05 | 199 | 112 | 6 | c81a194f8c2f120c6c4d74857912865a3c2fe1e7 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.13e-05 | 199 | 112 | 6 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.13e-05 | 199 | 112 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.13e-05 | 199 | 112 | 6 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.13e-05 | 199 | 112 | 6 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 112 | 6 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 112 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | mLN-T_cell-cycling_gd_T|mLN / Region, Cell class and subclass | 1.16e-05 | 200 | 112 | 6 | 4efeef51f885ee8f6dd3911a536cc49e3c14da98 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 112 | 6 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-BMP_responsible_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-05 | 200 | 112 | 6 | 5fb90118d3abc28d72bc483e68317255090a04c7 | |
| ToppCell | mLN-(1)_T_cell-(18)_cycling_gd_T|mLN / shred on region, Cell_type, and subtype | 1.16e-05 | 200 | 112 | 6 | e8a0a88a8344e80783931115bbe6cd5b62a4c1f7 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 1.16e-05 | 200 | 112 | 6 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 1.16e-05 | 200 | 112 | 6 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 112 | 6 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | LPS-antiTNF-Unknown|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.88e-05 | 129 | 112 | 5 | 739b263296c28554967362060b154f7a95e1341d | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-05 | 130 | 112 | 5 | 615c233c7c2600c1c2bc5cf5b1c501fc474564ef | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-05 | 132 | 112 | 5 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-innate_lymphocytic-immature_natural_killer_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.41e-05 | 146 | 112 | 5 | 40fac8a298152ec7f7eeeed5a2d28541aea3b338 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.41e-05 | 146 | 112 | 5 | 159dd157a74f3c27dc1a1dcbbf0ed8f9462cac9e | |
| ToppCell | Leuk-UTI-Myeloid-tDC|Leuk-UTI / Disease, Lineage and Cell Type | 5.43e-05 | 161 | 112 | 5 | 51b9f60986ed2e8e2297d31c80462c3ab65a2e5e | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.76e-05 | 163 | 112 | 5 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.93e-05 | 164 | 112 | 5 | 5621c2e3fae84d5a2e4f1595e454bcb3a2b3f93c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.10e-05 | 165 | 112 | 5 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.46e-05 | 167 | 112 | 5 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-05 | 168 | 112 | 5 | 04a7810f95196a21325356b42084f96c11af5964 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.65e-05 | 168 | 112 | 5 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 169 | 112 | 5 | da607c1d068038d5a3d1117f6aa6e4c6f3552e97 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.83e-05 | 169 | 112 | 5 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 169 | 112 | 5 | a14b46231e079a0fd9f3ca13d5d48113be76fd0f | |
| ToppCell | Control-T/NK_proliferative|World / Disease group and Cell class | 6.83e-05 | 169 | 112 | 5 | fca735cbb55fce4d32dc6632a39acea1d16b87ab | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l14|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.83e-05 | 169 | 112 | 5 | 813472d429c0b12580b17b440e00a6d8beb7947f | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.43e-05 | 172 | 112 | 5 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.06e-05 | 175 | 112 | 5 | 910a075ccaf79de22338ecf321fa0a867f3d7d75 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.06e-05 | 175 | 112 | 5 | f0c2eb82e17e8aec2cfa5d83169178f409cc1abc | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.06e-05 | 175 | 112 | 5 | 0b1aaa028ba844d4bcb4509fdab8bee648373935 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.06e-05 | 175 | 112 | 5 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.06e-05 | 175 | 112 | 5 | 74800a10f5ff25d5414fbccb0668f92ff077d1cc | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 8.28e-05 | 176 | 112 | 5 | ce2c32b5ce0da848eb4da35ce4d215cdf74d9113 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-05 | 176 | 112 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 8.50e-05 | 177 | 112 | 5 | 844017225e9039d1bc621a9630a30c2e9a51b36d | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.50e-05 | 177 | 112 | 5 | 26c25d10aa511b64cc7db43a8deea7b5d31bca96 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 179 | 112 | 5 | 7ae67e1c09a4ce9b3bcec4c48ee9cf2b1cb4e339 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.96e-05 | 179 | 112 | 5 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | CV-Healthy-2|CV / Virus stimulation, Condition and Cluster | 9.20e-05 | 180 | 112 | 5 | e182e5c495dd82d4fcbf1a920086c70b064801f3 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.20e-05 | 180 | 112 | 5 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.44e-05 | 181 | 112 | 5 | d74ee84146a72fd7cddf287f2e66d47d2c683bc4 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-05 | 181 | 112 | 5 | 3fe648db1cb8326066d8bde3ca1287c5c9af19bd | |
| ToppCell | IIH-cycling-|IIH / Condition, Cell_class and T cell subcluster | 9.44e-05 | 181 | 112 | 5 | 7f4fed9e296bc22cb5a1e6c8e3c4b641e97c3078 | |
| ToppCell | IIH-cycling|IIH / Condition, Cell_class and T cell subcluster | 9.44e-05 | 181 | 112 | 5 | ec3e782ce93dcfe1a54fb7284e4e39063614b0e2 | |
| ToppCell | Healthy_Control-Lymphoid-T-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 9.44e-05 | 181 | 112 | 5 | ac1ee313910c05b1b3cb497bae14565464919c21 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.44e-05 | 181 | 112 | 5 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.44e-05 | 181 | 112 | 5 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-05 | 182 | 112 | 5 | 39f9b3eb22293cc27c6e175702c77d1eeb24fdc9 | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 9.69e-05 | 182 | 112 | 5 | 9adf90bb2808f234d53b89ca0ae07380478204ad | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-05 | 182 | 112 | 5 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-05 | 182 | 112 | 5 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.69e-05 | 182 | 112 | 5 | b1e66ccd5f33b4801f1cafddf97f5fc0c6dba8d1 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-05 | 183 | 112 | 5 | 92ef926e6c1de8477fa4f35d1dae85482d8009de | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-05 | 183 | 112 | 5 | 24db9cc717e651586317c6a8e03a3401651273c1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.94e-05 | 183 | 112 | 5 | 54782c2e23bbeca5b683aa931393b1118da4aa37 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease group and Cell class | 9.94e-05 | 183 | 112 | 5 | 09c2b4e630f1c338f02c1242e3598e870d6b0a28 | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 9.94e-05 | 183 | 112 | 5 | df8568751205313d149939ea2683097e3652a60b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 184 | 112 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 184 | 112 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 184 | 112 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 184 | 112 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | URO-Lymphocyte-T_NK-T_NK_proliferative|URO / Disease, Lineage and Cell Type | 1.05e-04 | 185 | 112 | 5 | 0ae9c646679c69a553eda670aef0e0495feb0286 | |
| ToppCell | COVID-cycling-|COVID / Condition, Cell_class and T cell subcluster | 1.05e-04 | 185 | 112 | 5 | eb74b8d36f7b749e04bc2ed4b36f7e1ac7bb6d5f | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.05e-04 | 185 | 112 | 5 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 1.05e-04 | 185 | 112 | 5 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 185 | 112 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.05e-04 | 185 | 112 | 5 | 9d424a8608b339dd6129c58d87626678d4ec4af7 | |
| Disease | microcephaly (implicated_via_orthology) | 2.31e-04 | 32 | 110 | 3 | DOID:10907 (implicated_via_orthology) | |
| Disease | intracranial volume measurement | 2.54e-04 | 33 | 110 | 3 | EFO_0004886 | |
| Disease | neutrophil count | CUX2 VPS45 PARP8 NUF2 CIT CABLES1 EHD3 BBX PAM YY1AP1 TNFAIP8 SLC4A4 PSKH2 HYDIN | 6.29e-04 | 1382 | 110 | 14 | EFO_0004833 |
| Disease | N-acetylglutamine measurement | 1.05e-03 | 13 | 110 | 2 | EFO_0800017 | |
| Disease | anemia (implicated_via_orthology) | 1.40e-03 | 15 | 110 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | Alzheimer disease, polygenic risk score | 1.61e-03 | 586 | 110 | 8 | EFO_0030082, MONDO_0004975 | |
| Disease | smoking behavior | 1.78e-03 | 341 | 110 | 6 | EFO_0004318 | |
| Disease | Myeloid Leukemia | 2.03e-03 | 18 | 110 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 2.03e-03 | 18 | 110 | 2 | C0023466 | |
| Disease | synophrys measurement | 2.12e-03 | 68 | 110 | 3 | EFO_0007906 | |
| Disease | Autosomal Recessive Primary Microcephaly | 3.03e-03 | 22 | 110 | 2 | C3711387 | |
| Disease | Primary microcephaly | 3.03e-03 | 22 | 110 | 2 | C0431350 | |
| Disease | cancer (implicated_via_orthology) | 3.36e-03 | 268 | 110 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | diacylglycerol 34:1 measurement | 3.60e-03 | 24 | 110 | 2 | EFO_0010352 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KMTEPFNFEKNENKL | 21 | Q9BXT4 | |
| EGDPMANFIKKNKAK | 541 | Q9BRD0 | |
| MKNLDAKQKKASPRA | 86 | O00175 | |
| LDPKEKQKYTDMAKE | 121 | Q8WY36 | |
| LKEGNKKLMKENDFL | 711 | Q9NXG0 | |
| AAMLKDNKKPFIKEA | 331 | P16219 | |
| DNKKPFIKEAAMAKL | 336 | P16219 | |
| VKPNDSPSKENVKKM | 676 | Q58F21 | |
| ENIRKNSAFLKKMPK | 1746 | Q86TB3 | |
| KEMPSVFGKENKKKQ | 316 | Q9NZN4 | |
| KFSEINPDMKKLKKA | 721 | P48960 | |
| FLAIQKNKPISKKEM | 4101 | Q8TCU4 | |
| KPTSSELQKMQEKQK | 841 | P19021 | |
| FKKASEDDIKKMPLD | 96 | P15336 | |
| KEPFIKMKQFLSDEQ | 606 | O14529 | |
| PNETKNKDLKLSFMK | 546 | Q9UKL3 | |
| KLIDFLQAKMDQPAK | 1221 | O14578 | |
| KKEQRDSSKDKMLAP | 506 | P36021 | |
| KNNMKIIDPDEEKAK | 176 | Q13356 | |
| EMQKKKEENNPKLLL | 81 | Q9H0G5 | |
| SSDEEEEQKKPMKNK | 271 | Q14978 | |
| NEIFMAIAKKLPKNE | 171 | P20339 | |
| MEEKQPQKTKEPSKE | 1 | Q8N6M8 | |
| KMEKLNGKESKDNPA | 361 | O60393 | |
| DKTEPIKGFQKAMVK | 251 | P11182 | |
| KEFNLEKMLSKPENF | 511 | P20585 | |
| MNKKQKVSAKDEPAS | 746 | Q8N3A8 | |
| PKDILKKQMQFADQA | 421 | A0AUZ9 | |
| NFTNKNMKEVKKSPK | 31 | Q9H079 | |
| EQKTTKKPFAIKVME | 81 | Q96QS6 | |
| AEKAFDKIQQPFMLK | 601 | O00370 | |
| PENDKRFQKKFEKMA | 121 | Q8NEM0 | |
| KLKKQNDIPNKFEMK | 951 | P46934 | |
| LNDMIDAIPKSKKNK | 146 | Q9H3C7 | |
| SPEEKEKLQKNMKEL | 3886 | Q03001 | |
| SKENSAKKEMKFEDP | 1426 | Q2KJY2 | |
| KQEPKEPALSMEAKK | 701 | Q8N187 | |
| NFMDKLQIKDKKLPL | 136 | P52789 | |
| SDPNFKKTKAMEKIL | 776 | Q9H501 | |
| FATKIKKMNDNDKDI | 386 | P56645 | |
| PKMALQAKQDGKKDV | 231 | Q96JN0 | |
| DSPEKLKNYKEKMKD | 246 | Q9BZD4 | |
| NFEKMPIQEKEASKK | 36 | Q6P3R8 | |
| KVKKQMQSDPHKLDF | 666 | Q8WXX7 | |
| LENPFKKMKNNIVDA | 866 | P48552 | |
| DPKMNASFSLKSKEK | 281 | P22413 | |
| KMVNDAEPDTKKAKT | 116 | Q9NVP1 | |
| AVMQKPKDKQIKDLF | 576 | Q2PPJ7 | |
| KPKSKTAQQIAKDME | 531 | P52756 | |
| INLFEKEKEMKKSPT | 126 | Q9NYZ3 | |
| ADFKMEEKNENLAKK | 476 | Q96JM4 | |
| GFLMKKEVQDEEKNK | 236 | P15559 | |
| IPKDDQEKMKELFKI | 66 | Q8IUC8 | |
| NKPMESLDLKDKTKV | 161 | Q9NWS6 | |
| EKAKKNAMPDKRENT | 761 | Q6WRI0 | |
| KSNVQVKFMPKEEKF | 1781 | Q4G0P3 | |
| IKEEPPMKKSQAANK | 2371 | Q4G0P3 | |
| KFIMDSLNKEPFRKN | 6 | Q8WYA0 | |
| QLEMFTPSKKKKVLE | 1021 | Q8N1I0 | |
| PSDLKKDMNETFKEK | 491 | Q8TDN4 | |
| KDMNETFKEKFPHIK | 496 | Q8TDN4 | |
| EKMTMEKQKDNPKFS | 31 | Q8IWX8 | |
| QKTKKAPLNFNSEKM | 1021 | O75417 | |
| NDLKLNPKMKEEYDK | 31 | Q6K0P9 | |
| LQLADKMAKERKFPK | 281 | Q86UW7 | |
| DKDEKFSVFMPKKLN | 3366 | Q0VDD8 | |
| GTKKPNADEMKQAKI | 986 | Q14527 | |
| KQVKKKAEPSEVDMN | 56 | Q9NR30 | |
| TPKQEEQKESEKMKS | 241 | Q96T23 | |
| KVQDFRPNQKLKKSM | 46 | Q8IZU8 | |
| NKKPKEEKFSMVILA | 361 | Q9H7H0 | |
| EKEKQMSEPLDQKKI | 356 | O43933 | |
| IQPNDFKKMKEFLAS | 1011 | A6NMZ7 | |
| EQFKQQLKEKPSEDM | 291 | O43395 | |
| KEKVKELPTLKDMDF | 231 | Q8TBX8 | |
| KDTEDINKPKKFMTF | 436 | Q8WTT2 | |
| EKFKESMDANKPTKN | 76 | O43903 | |
| AEELQEFKKPMKKDI | 586 | Q9NYV6 | |
| LFQVKPANQKKMEET | 371 | A2RUB1 | |
| QPDLSKFKMEKLDKD | 241 | Q02880 | |
| ELAQKAKQAKPKDMV | 661 | A0AVI2 | |
| DGKKQLQKDFAAMKK | 141 | Q92901 | |
| MKKNEENTKTKNKPL | 141 | P35251 | |
| KAPKKQIQFADDMQE | 36 | O43865 | |
| AQTKNKKENMKPAAK | 1011 | Q5UIP0 | |
| EKNFYKKTPKEDKEM | 631 | A6NCM1 | |
| ENKSENKKTVPQKKM | 311 | Q5FBB7 | |
| QDRMYQKDPVKAKTK | 656 | Q96T21 | |
| NEKLKKKEFEMSNLQ | 1081 | Q9Y623 | |
| FNQDELALMEKFKKK | 91 | O95379 | |
| KEMPSVFGKDNKKKE | 316 | Q9NZN3 | |
| EKMKKSKDAAFQNVL | 341 | Q8NBU5 | |
| KNPKFMETVAEKALQ | 426 | P10909 | |
| PTEKKEANPKLNMVK | 86 | O95985 | |
| KKNQKGQEEVEMPSK | 1441 | Q14690 | |
| VDKIFSKMDKNKDDQ | 151 | P62760 | |
| PNKKIAKKNAAEAML | 356 | Q9NUL3 | |
| NFKVGMKLEAIDKKN | 171 | Q9UQR0 | |
| QIPEKMQKAFDDIAK | 16 | O60225 | |
| PEKQDIMKKLKEIAF | 101 | Q96FJ0 | |
| LTDKMKFEELKIPKD | 201 | Q8WUN7 | |
| EGNKKSSKKQFPNDM | 221 | Q92800 | |
| KNKFMKKIPKDSEAS | 291 | Q9BY07 | |
| NIKNLMEDFQKKKPK | 286 | Q9NRW7 | |
| MEDFQKKKPKEQQKL | 291 | Q9NRW7 | |
| KINEMKTFNSPNLKD | 1046 | Q9Y6N7 | |
| EDPKNKKDAKSNYKM | 161 | O00193 | |
| QLSKAAMKEDAKPSK | 176 | O60343 | |
| ELFEQLKMKKPSAKQ | 126 | Q9H869 | |
| TKNEELFQKEDMPKD | 181 | Q9H4T2 | |
| KELGKEETKQKNMPS | 1136 | Q9ULD9 | |
| MDADKEKDLQKFLKN | 1 | Q9H892 | |
| YDLPQKKQEKMTKFQ | 6 | Q86WZ6 | |
| ISDKPEKDQLKNKFM | 261 | Q9Y6R1 | |
| EKDQLKNKFMKKLPR | 266 | Q9Y6R1 | |
| KNKFMKKLPRDAEAS | 271 | Q9Y6R1 | |
| PKMADVSAEEKKKQD | 101 | Q9BSL1 | |
| MKKLTPKQKFSEDLE | 96 | Q5FWF6 | |
| KDGKPEMNKQIKNLE | 861 | Q9UM54 | |
| KEFQIKEDIPETKMK | 56 | Q13287 |